“The moves [Arbortext is] making in the pharmaceutical industry are fairly significant,” said Ron Schmelzer, an analyst with ZapThink LLC, in Cambridge, Mass. “They are applying this technology to solve some serious, heavy problems in pharmaceuticals. … The whole drug discovery to product development to product release is a complicated, heavily regulated process that requires a ton of documentation.”

Read more at: eWeek